Skip to content

Fractional CO₂ Laser Before Follicular Unit Extraction Hair Transplantation With Platelet-Rich Plasma for Secondary Cicatricial Alopecia

Effect of Preoperative Fractional CO₂ Laser on the Outcome of Follicular Unit Extraction Hair Transplantation Combined With Intraoperative Platelet-Rich Plasma in Patients With Secondary Cicatricial Alopecia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07751523
Acronym
CO2-FUE-PRP
Enrollment
20
Registered
2026-08-07
Start date
2024-05-02
Completion date
2026-05-30
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair Transplantation

Keywords

cicatricial alopecia, fractional CO2, PRP, Hair Transplantation

Brief summary

Secondary cicatricial alopecia is characterized by permanent hair loss due to destruction of hair follicles following trauma, burns, infection, or other causes. Hair transplantation using follicular unit extraction (FUE) is an established treatment; however, graft survival may be limited by poor vascularity and fibrosis within scar tissue. Fractional carbon dioxide (CO₂) laser has been proposed to improve the recipient site by enhancing tissue remodeling and vascularization before transplantation. This prospective comparative clinical study evaluated the effect of three preoperative sessions of fractional CO₂ laser followed by FUE hair transplantation with intraoperative platelet-rich plasma (PRP) injection compared with FUE hair transplantation combined with intraoperative PRP alone in patients with stable secondary cicatricial alopecia. Twenty participants were allocated into two groups of 10 patients each and were followed for 9 months after hair transplantation. The primary objective was to determine whether preoperative fractional CO₂ laser improves the clinical outcome of FUE hair transplantation in secondary cicatricial alopecia. Outcomes included clinical improvement, dermoscopic assessment of hair growth, patient satisfaction, and scar assessment.

Detailed description

Secondary cicatricial alopecia is characterized by permanent destruction of hair follicles resulting from trauma, burns, infection, radiation, or other non-follicular pathological processes. Hair transplantation using follicular unit extraction (FUE) is an established surgical treatment for stable secondary cicatricial alopecia; however, graft survival and cosmetic outcomes may be compromised by fibrosis, reduced vascularity, and poor tissue elasticity within scarred recipient sites. Fractional carbon dioxide (CO₂) laser has been suggested to improve scar quality by promoting tissue remodeling, neovascularization, and wound healing, potentially enhancing the recipient bed before hair transplantation. Platelet-rich plasma (PRP), which contains a high concentration of growth factors, may further improve graft survival and hair growth by stimulating tissue regeneration. This prospective comparative clinical study was conducted to evaluate whether preoperative fractional CO₂ laser treatment improves the outcome of FUE hair transplantation combined with intraoperative PRP injection in patients with stable secondary cicatricial alopecia. Twenty participants of both sexes with stable secondary cicatricial alopecia and realistic treatment expectations were enrolled. Patients with chronic systemic diseases, pregnancy or lactation, platelet or blood disorders, history of keloid formation, scar duration less than one year, or inadequate donor sites were excluded. The study was approved by the Research Ethics Committee of Tanta University Hospitals (Approval No. 34430/1/21), and written informed consent was obtained from all participants before enrollment. Participants were assigned into two treatment groups. Group A received three sessions of fractional CO₂ laser treatment at one-month intervals before surgery, followed one month later by FUE hair transplantation combined with intraoperative PRP injection. Group B underwent direct FUE hair transplantation combined with intraoperative PRP injection without preoperative laser treatment. PRP was prepared from autologous venous blood using a double-centrifugation technique and injected into the recipient scar tissue during the transplantation procedure. Hair grafts were harvested using the FUE technique from the donor area and transplanted into the scarred recipient site according to standard surgical protocols. Participants were followed for nine months after hair transplantation. Clinical assessment included standardized photographic evaluation by three blinded dermatologists and two plastic surgeons. Dermoscopic examination was performed before and after treatment to evaluate follicular regeneration and the percentage of scar surface covered by growing hair. Patient satisfaction and scar severity were also assessed using validated scar assessment scales. The primary objective was to determine whether preoperative fractional CO₂ laser enhances the clinical outcome of FUE hair transplantation with intraoperative PRP in patients with secondary cicatricial alopecia. Secondary objectives included evaluation of dermoscopic hair regrowth, patient satisfaction, and changes in scar assessment scores

Interventions

PROCEDUREhair transplantation preceded by fractional and PRP

intervention injection

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* Patients with stable secondary cicatricial alopecia. Male or female participants. Participants with realistic expectations regarding treatment outcomes. All hair types (silky, curly, or normal hair). Presence of an adequate donor site for follicular unit extraction (FUE). Ability and willingness to provide written informed consent.

Exclusion criteria

* Extremes of age. Chronic systemic diseases, including hepatic or renal disease. Receiving chemotherapy or systemic corticosteroid therapy. Platelet disorders or other blood disorders. Pregnancy or lactation. History of keloid formation. Scar duration less than 1 year. Absence of a suitable donor site for hair transplantation

Design outcomes

Primary

MeasureTime frameDescription
Clinical improvement after hair transplantation9 months after follicular unit extraction (FUE) hair transplantationExcellent (\>75% improvement) Good (50-75%) Fair (25-49%) Poor (\<25%)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026